Niagen Bioscience, Inc. (NAGE) — Cash Flow-to-Debt Ratio
Niagen Bioscience, Inc. (NAGE) has a Cash Flow-to-Debt Ratio of 0.13x as of September 2025, meaning its operating cash flow of $3.69 Million could theoretically repay 0% of its total liabilities ($27.46 Million) in one year. See how much free cash does Niagen Bioscience, Inc. generate to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Niagen Bioscience, Inc. Cash Flow-to-Debt Ratio (2007–2024)
Historical debt coverage capacity for Niagen Bioscience, Inc. across 18 annual periods. Also explore net asset momentum of Niagen Bioscience, Inc. to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Niagen Bioscience, Inc. (2007–2024)
Year-by-year debt coverage analysis for Niagen Bioscience, Inc.. For market capitalisation and broader financial context, see NAGE market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.55x | $12.11 Million | $22.18 Million | ▲ +103.3% |
| 2023 | 0.27x | $7.12 Million | $26.51 Million | ▲ +145.1% |
| 2022 | -0.59x | $-15.10 Million | $25.39 Million | ▲ +35.7% |
| 2021 | -0.93x | $-24.16 Million | $26.11 Million | ▼ -91.5% |
| 2020 | -0.48x | $-10.60 Million | $21.93 Million | ▲ +53.2% |
| 2019 | -1.03x | $-20.44 Million | $19.80 Million | ▲ +25.7% |
| 2018 | -1.39x | $-20.91 Million | $15.05 Million | ▼ -25.9% |
| 2017 | -1.10x | $-9.80 Million | $8.89 Million | ▼ -267.2% |
| 2016 | -0.30x | $-2.94 Million | $9.78 Million | ▼ -91.7% |
| 2015 | -0.16x | $-2.11 Million | $13.47 Million | ▲ +54.3% |
| 2014 | -0.34x | $-2.58 Million | $7.52 Million | ▲ +70.8% |
| 2013 | -1.18x | $-3.91 Million | $3.32 Million | ▲ +41.4% |
| 2012 | -2.01x | $-10.12 Million | $5.04 Million | ▼ -81.6% |
| 2011 | -1.11x | $-4.10 Million | $3.71 Million | ▲ +34.8% |
| 2010 | -1.69x | $-2.66 Million | $1.57 Million | ▼ -976.5% |
| 2009 | -0.16x | $-396.17K | $2.52 Million | ▲ +80.9% |
| 2008 | -0.82x | $-1.92 Million | $2.33 Million | ▲ +99.1% |
| 2007 | -96.21x | $-38.48K | $400.00 | — |